Skip to main content
Equibles
BTSG logo

BTSG · BrightSpring Health Services, Inc. · Metrics

Track BTSG — free

Use BTSG with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research BTSG.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$62.24 +0.95 (+1.55%)
S&P 400 member Russell 2000 member Rebalance outlook locked
Market Cap
$12.10B
Shares
197.86M
Volume · Oct 20 339.2K Avg daily vol (3M) 2.57M

BTSG metrics

97 of 122 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$61.29
Market cap
$12.10B

Price action

20 metrics
Price change (1W)
-2.7%
Price change (30D)
+9.7%
Price change (3M)
-13.1%
Price change (6M)
+28.2%
Price change (YTD)
+63.7%
Price change (1Y)
+106.2%
Trailing year
Price change (5Y)
—
52-week high
$72.91
52-week low
$30.47
Change from 52-week high
-15.9%
Change from 52-week low
+101.1%
Annualized volatility
43.8%
Annualized volatility (3M)
55.0%
Beta
1.3
RSI (14D)
52.1
Price vs SMA 50
+2.6%
Price vs SMA 200
+14.2%
Avg volume (3M)
2.57M
Relative volume
0.5
Average dollar volume
$157.82M

Company

3 metrics
Sector
Healthcare
Industry
Health Information Services
Shares outstanding
197.86M

Valuation

12 metrics
P / E (TTM)
37.1
Trailing earnings · reciprocal yield 2.7%
PEG ratio
0.2
EV / revenue
1.0×
reciprocal yield 104.6%
EV / EBITDA
22.6×
reciprocal yield 4.4%
EV / EBIT
30.7×
reciprocal yield 3.3%
P / sales
0.8×
reciprocal yield 118.8%
P / book
5.9
reciprocal yield 16.9%
FCF yield
3.3%
TTM · current market cap
Buyback yield
—
P / FCF
30.1
reciprocal yield 3.3%
P / operating cash flow
23.9
reciprocal yield 4.2%
Earnings yield
3.0%

Historical valuation

8 metrics
P / E historical average (3Y)
47.6×
reciprocal yield 2.1%
P / E historical average (5Y)
47.6×
reciprocal yield 2.1%
EV / revenue historical average (3Y)
0.7×
reciprocal yield 147.7%
EV / revenue historical average (5Y)
0.7×
reciprocal yield 147.7%
EV / EBIT historical average (3Y)
27.6×
reciprocal yield 3.6%
EV / EBIT historical average (5Y)
27.6×
reciprocal yield 3.6%
EV / EBITDA historical average (3Y)
16.7×
reciprocal yield 6.0%
EV / EBITDA historical average (5Y)
16.7×
reciprocal yield 6.0%

Dividends & buybacks

7 metrics
Dividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—

Earnings calendar

2 metrics
Next earnings
2026-10-30
Last earnings
2026-07-31

Profitability

9 metrics
Gross margin
12.4%
Operating margin
3.1%
Trailing 12 months
Net margin
2.5%
Gross profit (TTM)
$1.78B
Operating profit (TTM)
$447.80M
Net income (TTM)
$365.97M
Trailing 12 months
Diluted EPS (TTM)
$1.65
FCF margin
2.8%
Effective tax rate
16.1%

Per share

11 metrics
Revenue per diluted share (TTM)
$64.66
Gross profit per diluted share (TTM)
$8.01
Operating profit per diluted share (TTM)
$2.01
EBITDA per diluted share (TTM)
$2.74
Net income per diluted share (TTM)
$1.65
Operating cash flow per diluted share (TTM)
$2.26
Free cash flow per diluted share (TTM)
$1.79
Capital expenditures per diluted share (TTM)
$0.47
R&D per diluted share (TTM)
—
Stock compensation per diluted share (TTM)
$0.25
Book value per share
$9.76

Growth

11 metrics
Revenue growth YoY
+23.0%
Year over year
Net income growth YoY
+198.8%
Revenue (TTM)
$14.37B
Trailing 12 months
EPS growth YoY
+192.3%
Shares change YoY
+1.8%
Year over year · more shares
Revenue CAGR (3Y)
+18.7%
Revenue CAGR (5Y)
—
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—

Quality

14 metrics
Return on equity
17.9%
Return on assets
6.1%
Debt / equity
1.1
Current ratio
1.6
EBITDA (TTM)
$608.59M
Free cash flow (TTM)
$402.35M
Quick ratio
1.2
Interest coverage
2.9
Net debt / EBITDA
2.7
Return on invested capital
10.2%
Trailing 12 months
Net cash
−$1.64B
Latest balance sheet
Cash & equivalents
$550.38M
Total assets
$5.99B
Total debt
$2.19B

Cash flow & spend

7 metrics
Operating cash flow (TTM)
$506.35M
Capital expenditures (TTM)
$104.00M
R&D (TTM)
—
SG&A (TTM)
$1.33B
Stock compensation (TTM)
$54.78M
R&D / revenue
—
Stock compensation / revenue
0.4%

Ownership (13F)

9 metrics
13F filers
443
13F filer change QoQ
+90
Institutional ownership
107.0%
Conviction holders (share of 13F filers)
—
Crowding (high-turnover and private-fund holders)
—
Private-fund adviser ownership
—
Active holders' share change QoQ
—
Holder tenure
—
Price vs estimated holder cost
—

Ownership (registered funds)

1 metrics
Index-fund ownership
23.2%

Short interest

3 metrics
Short interest
6.1%
Latest settlement · 4.4 days to cover
Days to cover
4.4d
Short-squeeze score
66 / 100

Insider activity

2 metrics
Net insider buying (90D)
−$874,383
Insider-sentiment score
—

Risk flags

1 metrics
Going concern
—
Key facts CIK 1865782 CUSIP 10950A106 13F (30d) 48 filings 47 filers Visit website Investor relations